NFKB1 and non-small cell lung carcinoma: Wang et al. [62] found that the inhibition of NF-κB by geldanamycin (GA) could be responsible for the synergistic apoptosis-inducing effect of GA and CDDP in NSCLC cells and tumor xenografts.